FOPPOLI, MARCO
FOPPOLI, MARCO
Facoltà di Medicina e Chirurgia
[Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]. FT Localizzazione cardiaca di linfoma non-Hodgkin in soggetto HIV positivo affetto da cardiomiopatia ipertrofica ostruttiva.
2012-01-01 Demarchi, Barbara; Foppoli, Marco; Contri, Rachele; Margonato, Alberto
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial
2021-01-01 Ferreri, A. J. M.; Cattaneo, C.; Lleshi, A.; Verga, L.; Allione, B.; Facchetti, F.; Ponzoni, M.; Foppoli, M.; Ferrari, D.; Rigacci, L.; Pecciarini, L.; Donadoni, G.; Fumagalli, L.; Sassone, M.; Calimeri, T.; Rossi, G.; Spina, M.; Re, A.
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
2021-01-01 Pesenti, G.; Foppoli, M.; Manca, D.
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas
2004-01-01 Ferreri, Ajm; Dell'Oro, S; Capello, D; Ponzoni, Maurilio; Iuzzolino, P; Rossi, D; Pasini, F; Ambrosetti, A; Orvieto, E; Ferrarese, F; Arrigoni, G; Foppoli, M; Reni, M; Gaidano, G.
Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration
2020-01-01 Pesenti, G.; Foppoli, M.; Savoca, A.; Manca, D.
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination
2011-01-01 Ferreri, Ajm; Licata, G; Foppoli, M; Corazzelli, G; Zucca, E; Stelitano, C; Zaja, F; Fava, S; Paolini, R; Franzin, A; Politi, Ls; Ponzoni, Maurilio; Reni, M.
Development of a whole-body physiologically-based pharmacokinetic model for high-dose methotrexate
2022-01-01 Pesenti, G.; Massari, D.; Foppoli, M.; Manca, D.
Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review
2023-01-01 Steffanoni, S.; Calimeri, T.; Marktel, S.; Nitti, R.; Foppoli, M.; Ferreri, A. J. M.
Gamma-delta t-cell lymphomas
2015-01-01 Foppoli, M.; Ferreri, A. J. M.
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial
2015-01-01 Ferreri, Ajm; Donadoni, G; Cabras, Mg; Patti, C; Mian, M; Zambello, R; Tarella, C; Di Nicola, M; D'Arco, Am; Doa, G; Bruno Ventre, M; Assanelli, A; Foppoli, M; Citterio, G; Fanni, A; Mule, A; Caligaris Cappio, F; Ciceri, Fabio
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
2009-01-01 Ferreri, Ajm; Reni, M; Foppoli, M; Martelli, M; Pangalis, Ga; Frezzato, M; Cabras, Mg; Fabbri, A; Corazzelli, G; Ilariucci, F; Rossi, G; Soffietti, R; Stelitano, C; Vallisa, D; Zaja, F; Zoppegno, L; Aondio, Gm; Avvisati, G; Balzarotti, M; Brandes, Aa; Fajardo, J; Gomez, H; Guarini, A; Pinotti, G; Rigacci, L; Uhlmann, C; Picozzi, P; Vezzulli, P; Ponzoni, Maurilio; Zucca, E; Caligaris Cappio, F; Cavalli, F.
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma
2021-01-01 Calimeri, T.; Steffanoni, S.; Foppoli, M.; Ponzoni, M.; Ferreri, A. J. M.
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial
2020-01-01 Ferreri, A. J. M.; Calimeri, T.; Ponzoni, M.; Curnis, F.; Conte, G. M.; Scarano, E.; Rrapaj, E.; De Lorenzo, D.; Cattaneo, D.; Fallanca, F.; Nonis, A.; Foppoli, M.; Lopedote, P.; Citterio, G.; Politi, L. S.; Sassone, M.; Angelillo, P.; Guggiari, E.; Steffanoni, S.; Tarantino, V.; Ciceri, F.; Bordignon, C.; Anzalone, N.; Corti, A.
Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure
2017-01-01 Cavalli, Giulio; Foppoli, Marco; Cabrini, Luca; Dinarello, Charles A.; Tresoldi, Moreno; Dagna, Lorenzo
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
2020-01-01 Ferreri, A. J. M.; Sassone, M.; Angelillo, P.; Zaja, F.; Re, A.; Di Rocco, A.; Spina, M.; Fabbri, A.; Stelitano, C.; Frezzato, M.; Volpetti, S.; Zambello, R.; Rusconi, C.; De Lorenzo, D.; Scarano, E.; Arcari, A.; Bertoldero, G.; Nonis, A.; Calimeri, T.; Perrone, S.; Cecchetti, C.; Tarantino, V.; Steffanoni, S.; Foppoli, M.; Ciceri, F.; Ponzoni, M.
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas
2006-01-01 Ferreri, Ajm; Dell'Oro, S; Foppoli, M; Bernardi, M; Brandes, Aa; Tosoni, A; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Stelitano, C; Bobbio, F; Corazzelli, G; Baldini, L; Ponzoni, Maurilio; Picozzi, P; Cappio, Fc; Reni, M.
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
2021-01-01 Ferreri, A. J. M.; Calimeri, T.; Lopedote, P.; Francaviglia, I.; Daverio, R.; Iacona, C.; Belloni, C.; Steffanoni, S.; Gulino, A.; Anghileri, E.; Diffidenti, A.; Finardi, A.; Gagliardi, F.; Anzalone, N.; Nonis, A.; Furlan, R.; De Lorenzo, D.; Terreni, M. R.; Martinelli, V.; Sassone, M.; Foppoli, M.; Angelillo, P.; Guggiari, E.; Falini, A.; Mortini, P.; Filippi, M.; Tarantino, V.; Eoli, M.; Ciceri, F.; Doglioni, C.; Tripodo, C.; Locatelli, M.; Cangi, M. G.; Ponzoni, M.
Optimal dose and uncertainty estimation for individualized drug administration using pharmacokinetic models
2021-01-01 Pesenti, G.; Foppoli, M.; Manca, D.
Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man
2015-01-01 Montanaro, C; Loiacono, F; Fragasso, G; DE COBELLI, Francesco; Foppoli, M; Margonato, Alberto
Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate
2007-01-01 Reni, M; Mazza, E; Foppoli, M; Ferreri, Ajm
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]. FT Localizzazione cardiaca di linfoma non-Hodgkin in soggetto HIV positivo affetto da cardiomiopatia ipertrofica ostruttiva. | 1-gen-2012 | Demarchi, Barbara; Foppoli, Marco; Contri, Rachele; Margonato, Alberto | |
| A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial | 1-gen-2021 | Ferreri, A. J. M.; Cattaneo, C.; Lleshi, A.; Verga, L.; Allione, B.; Facchetti, F.; Ponzoni, M.; Foppoli, M.; Ferrari, D.; Rigacci, L.; Pecciarini, L.; Donadoni, G.; Fumagalli, L.; Sassone, M.; Calimeri, T.; Rossi, G.; Spina, M.; Re, A. | |
| A minimal physiologically based pharmacokinetic model for high-dose methotrexate | 1-gen-2021 | Pesenti, G.; Foppoli, M.; Manca, D. | |
| Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas | 1-gen-2004 | Ferreri, Ajm; Dell'Oro, S; Capello, D; Ponzoni, Maurilio; Iuzzolino, P; Rossi, D; Pasini, F; Ambrosetti, A; Orvieto, E; Ferrarese, F; Arrigoni, G; Foppoli, M; Reni, M; Gaidano, G. | |
| Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration | 1-gen-2020 | Pesenti, G.; Foppoli, M.; Savoca, A.; Manca, D. | |
| Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination | 1-gen-2011 | Ferreri, Ajm; Licata, G; Foppoli, M; Corazzelli, G; Zucca, E; Stelitano, C; Zaja, F; Fava, S; Paolini, R; Franzin, A; Politi, Ls; Ponzoni, Maurilio; Reni, M. | |
| Development of a whole-body physiologically-based pharmacokinetic model for high-dose methotrexate | 1-gen-2022 | Pesenti, G.; Massari, D.; Foppoli, M.; Manca, D. | |
| Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review | 1-gen-2023 | Steffanoni, S.; Calimeri, T.; Marktel, S.; Nitti, R.; Foppoli, M.; Ferreri, A. J. M. | |
| Gamma-delta t-cell lymphomas | 1-gen-2015 | Foppoli, M.; Ferreri, A. J. M. | |
| High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial | 1-gen-2015 | Ferreri, Ajm; Donadoni, G; Cabras, Mg; Patti, C; Mian, M; Zambello, R; Tarella, C; Di Nicola, M; D'Arco, Am; Doa, G; Bruno Ventre, M; Assanelli, A; Foppoli, M; Citterio, G; Fanni, A; Mule, A; Caligaris Cappio, F; Ciceri, Fabio | |
| High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | 1-gen-2009 | Ferreri, Ajm; Reni, M; Foppoli, M; Martelli, M; Pangalis, Ga; Frezzato, M; Cabras, Mg; Fabbri, A; Corazzelli, G; Ilariucci, F; Rossi, G; Soffietti, R; Stelitano, C; Vallisa, D; Zaja, F; Zoppegno, L; Aondio, Gm; Avvisati, G; Balzarotti, M; Brandes, Aa; Fajardo, J; Gomez, H; Guarini, A; Pinotti, G; Rigacci, L; Uhlmann, C; Picozzi, P; Vezzulli, P; Ponzoni, Maurilio; Zucca, E; Caligaris Cappio, F; Cavalli, F. | |
| Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma | 1-gen-2021 | Calimeri, T.; Steffanoni, S.; Foppoli, M.; Ponzoni, M.; Ferreri, A. J. M. | |
| Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial | 1-gen-2020 | Ferreri, A. J. M.; Calimeri, T.; Ponzoni, M.; Curnis, F.; Conte, G. M.; Scarano, E.; Rrapaj, E.; De Lorenzo, D.; Cattaneo, D.; Fallanca, F.; Nonis, A.; Foppoli, M.; Lopedote, P.; Citterio, G.; Politi, L. S.; Sassone, M.; Angelillo, P.; Guggiari, E.; Steffanoni, S.; Tarantino, V.; Ciceri, F.; Bordignon, C.; Anzalone, N.; Corti, A. | |
| Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure | 1-gen-2017 | Cavalli, Giulio; Foppoli, Marco; Cabrini, Luca; Dinarello, Charles A.; Tresoldi, Moreno; Dagna, Lorenzo | |
| Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation | 1-gen-2020 | Ferreri, A. J. M.; Sassone, M.; Angelillo, P.; Zaja, F.; Re, A.; Di Rocco, A.; Spina, M.; Fabbri, A.; Stelitano, C.; Frezzato, M.; Volpetti, S.; Zambello, R.; Rusconi, C.; De Lorenzo, D.; Scarano, E.; Arcari, A.; Bertoldero, G.; Nonis, A.; Calimeri, T.; Perrone, S.; Cecchetti, C.; Tarantino, V.; Steffanoni, S.; Foppoli, M.; Ciceri, F.; Ponzoni, M. | |
| MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas | 1-gen-2006 | Ferreri, Ajm; Dell'Oro, S; Foppoli, M; Bernardi, M; Brandes, Aa; Tosoni, A; Montanari, M; Balzarotti, M; Spina, M; Ilariucci, F; Zaja, F; Stelitano, C; Bobbio, F; Corazzelli, G; Baldini, L; Ponzoni, Maurilio; Picozzi, P; Cappio, Fc; Reni, M. | |
| MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study | 1-gen-2021 | Ferreri, A. J. M.; Calimeri, T.; Lopedote, P.; Francaviglia, I.; Daverio, R.; Iacona, C.; Belloni, C.; Steffanoni, S.; Gulino, A.; Anghileri, E.; Diffidenti, A.; Finardi, A.; Gagliardi, F.; Anzalone, N.; Nonis, A.; Furlan, R.; De Lorenzo, D.; Terreni, M. R.; Martinelli, V.; Sassone, M.; Foppoli, M.; Angelillo, P.; Guggiari, E.; Falini, A.; Mortini, P.; Filippi, M.; Tarantino, V.; Eoli, M.; Ciceri, F.; Doglioni, C.; Tripodo, C.; Locatelli, M.; Cangi, M. G.; Ponzoni, M. | |
| Optimal dose and uncertainty estimation for individualized drug administration using pharmacokinetic models | 1-gen-2021 | Pesenti, G.; Foppoli, M.; Manca, D. | |
| Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man | 1-gen-2015 | Montanaro, C; Loiacono, F; Fragasso, G; DE COBELLI, Francesco; Foppoli, M; Margonato, Alberto | |
| Primary central nervous system lymphomas: Salvage treatment after failure to high-dose methotrexate | 1-gen-2007 | Reni, M; Mazza, E; Foppoli, M; Ferreri, Ajm |